Atrial fibrillation: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Atrial fibrillation}} | {{Atrial fibrillation}} | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
| Line 15: | Line 14: | ||
| [[Image:Heart conduct atrialfib.gif|150px]]<BR><small>'''Atrial fibrillation'''</small> | | [[Image:Heart conduct atrialfib.gif|150px]]<BR><small>'''Atrial fibrillation'''</small> | ||
|} | |} | ||
{{Patient}} | {{Patient}} | ||
{{CMG}} | {{CMG}} | ||
Revision as of 19:21, 26 October 2016
|
Atrial Fibrillation Microchapters | |
|
Special Groups | |
|---|---|
|
Diagnosis | |
|
Treatment | |
|
Cardioversion | |
|
Anticoagulation | |
|
Surgery | |
|
Case Studies | |
|
Atrial fibrillation On the Web | |
 |
Resident Survival Guide |
 Sinus rhythm |
 Atrial fibrillation |
For patient information, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: AF; afib; lone fibrillator
Overview
Classification
Pathophysiology
Causes
Differentiating Atrial Fibrillation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Special Groups
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hypertrophic Cardiomyopathy | Hyperthyroidism | Pulmonary Diseases | Pregnancy | Patients Presenting with ACS and/or PCI or Valve Intervention
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Afib with LBBB EKG Examples | Chest X Ray | Echocardiography | Holter Monitoring and Exercise Stress Testing | Cardiac MRI
Treatment
Cardioversion
Overview | Electrical Cardioversion | Pharmacological Cardioversion
Anticoagulation
Overview | Warfarin | Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants | Dabigatran
Dabigatran
Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Rate and Rhythm Control
Rate Control | Maintenance of Sinus Rhythm
Ablation
Catheter Ablation | AV Nodal Ablation | Surgical Ablation
Surgery
Contraindicated medications
Atrial fibrillation is considered an absolute contraindication to the use of the following medications:
Permanent atrial fibrillation is considered an absolute contraindication to the use of the following medications: